Dickinson College (Carlisle, PA) will host Dr. Alan Davis, director of the Center for Psychedelic Drug Research and Education at Ohio State University, to deliver a lecture at Dickinson discussing their work using psychedelic-assisted therapies in mental health treatment. The talk, “Psychedelic-Assisted Psychotherapy: A Promising Intervention Mental Health Treatment,” will take place Thursday, March 9, at 7 p.m. in the Anita Tuvin Schlechter (ATS) Auditorium. The event is free and open to the public. Masks are optional but welcome. The lecture will be livestreamed via YouTube live.
Davis will address their work on psychedelic-assisted interventions for mental health issues, specifically focusing on the positive clinical outcomes following the administration of psylocibin—a naturally occurring psychedelic compound which can be isolated from more than 200 fresh and dried forms of fungi. Davis will discuss the possible acute effects of these treatments, the value of contemporary pre-clinical research and the importance of destigmatizing psychedelic treatments in clinical settings.
Davis is a clinical psychologist and assistant professor of social work and psychiatry at OSU and holds a faculty appointment in the Department of Psychiatry at Johns Hopkins University. Davis’ research includes the exploration of alternative treatments for addiction and mental health issues, such as the use of psychedelic therapies. They have published more than 80 scientific articles, in addition to being involved in preclinical animal psychedelic research and piloting a study of the first human trial for psilocybin-based post-traumatic stress disorder treatment.
The event is co-sponsored by the departments of psychology and chemistry, as well as the Pre-Health Program. This event was initiated by the Clarke Forum’s student project managers. For more information, visit www.clarkeforum.org
